Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:1642-1650, 2006
DOI: 10.2337/db05-1477
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menini, S.
Right arrow Articles by Pugliese, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menini, S.
Right arrow Articles by Pugliese, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Deletion of p66Shc Longevity Gene Protects Against Experimental Diabetic Glomerulopathy by Preventing Diabetes-Induced Oxidative Stress

Stefano Menini1, Lorena Amadio1,2, Giovanna Oddi1,2, Carlo Ricci1, Carlo Pesce3, Francesco Pugliese1, Marco Giorgio4, Enrica Migliaccio4, PierGiuseppe Pelicci4, Carla Iacobini1,2, and Giuseppe Pugliese1

1 Department of Clinical Sciences, "La Sapienza" University, Rome, Italy
2 Department of Cell Biology and Neurosciences, National Institute of Health of Italy, Rome, Italy
3 DISTBIMO, University of Genoa Medical School, Genoa, Italy
4 Department of Experimental Oncology, European Institute of Oncology, Milan, Italy

Address correspondence and reprint requests to Giuseppe Pugliese, MD, PhD, Dipartimento di Scienze Cliniche (Endocrinologia), Viale del Policlinico, 155-00161 Rome, Italy. E-mail: giuseppe.pugliese{at}uniroma1.it

Abbreviations: AGE, advanced glycation end product; CM-H2DCFDA, 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate; CML, carboxymethyllysine; ECM, extracellular matrix; ELISA, enzyme-linked immunosorbent assay; HNE, hydroxy-2-nonenal; NF-{kappa}B, nuclear factor {kappa}B; PAS, periodic acid Schiff; PKC, protein kinase C; RAGE, receptor for AGEs; ROS, reactive oxygen species; TID, tubulointerstitial damage

p66Shc regulates both steady-state and environmental stress-dependent reactive oxygen species (ROS) generation. Its deletion was shown to confer resistance to oxidative stress and protect mice from aging-associated vascular disease. This study was aimed at verifying the hypothesis that p66Shc deletion also protects from diabetic glomerulopathy by reducing oxidative stress. Streptozotocin-induced diabetic p66Shc knockout (KO) mice showed less marked changes in renal function and structure, as indicated by the significantly lower levels of proteinuria, albuminuria, glomerular sclerosis index, and glomerular and mesangial areas. Glomerular content of fibronectin and collagen IV was also lower in diabetic KO versus wild-type mice, whereas apoptosis was detected only in diabetic wild-type mice. Serum and renal tissue advanced glycation end products and plasma isoprostane 8-epi-prostaglandin F2{alpha} levels and activation of nuclear factor {kappa}B (NF-{kappa}B) were also lower in diabetic KO than in wild-type mice. Mesangial cells from KO mice grown under high-glucose conditions showed lower cell death rate, matrix production, ROS levels, and activation of NF-{kappa}B than those from wild-type mice. These data support a role for oxidative stress in the pathogenesis of diabetic glomerulopathy and indicate that p66Shc is involved in the molecular mechanism(s) underlying diabetes-induced oxidative stress and oxidant-dependent renal injury.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Zaccagnini, F. Martelli, A. Magenta, C. Cencioni, P. Fasanaro, C. Nicoletti, P. Biglioli, P. G. Pelicci, and M. C. Capogrossi
p66ShcA and Oxidative Stress Modulate Myogenic Differentiation and Skeletal Muscle Regeneration after Hind Limb Ischemia
J. Biol. Chem., October 26, 2007; 282(43): 31453 - 31459.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Cai, J. C. He, L. Zhu, X. Chen, S. Wallenstein, G. E. Striker, and H. Vlassara
Reduced Oxidant Stress and Extended Lifespan in Mice Exposed to a Low Glycotoxin Diet: Association with Increased AGER1 Expression
Am. J. Pathol., June 1, 2007; 170(6): 1893 - 1902.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. G. Camici, M. Schiavoni, P. Francia, M. Bachschmid, I. Martin-Padura, M. Hersberger, F. C. Tanner, P. Pelicci, M. Volpe, P. Anversa, et al.
Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress
PNAS, March 20, 2007; 104(12): 5217 - 5222.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C.-L. Lin, J.-Y. Wang, Y.-T. Huang, Y.-H. Kuo, K. Surendran, and F.-S. Wang
Wnt/beta-Catenin Signaling Modulates Survival of High Glucose-Stressed Mesangial Cells
J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2812 - 2820.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.